evans blue has been researched along with chenodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, K; Erickson, RA; Lifrak, E; Rivera, N; Stachura, J | 1 |
2 other study(ies) available for evans blue and chenodeoxycholic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
16,16-Dimethyl prostaglandin E2 reduces bile acid-mediated intestinal vascular injury in rats.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Blood Pressure; Body Water; Capillary Permeability; Chenodeoxycholic Acid; Dextrans; Evans Blue; Fluorescein-5-isothiocyanate; Intestinal Mucosa; Rats | 1992 |